High-dose, short-course levofloxacin for community-acquired pneumonia: A new treatment paradigm

Lala M. Dunbar, Richard G. Wunderink, Michael P. Habib, Leon G. Smith, Alan M. Tennenberg*, Mohammed M. Khashab, Barbara A. Wiesinger, Jim X. Xiang, Neringa Zadeikis, James B. Kahn

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

292 Scopus citations

Fingerprint

Dive into the research topics of 'High-dose, short-course levofloxacin for community-acquired pneumonia: A new treatment paradigm'. Together they form a unique fingerprint.

Medicine & Life Sciences